Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.90+0.94 (+3.77%)
At close: 04:00PM EDT
25.77 -0.13 (-0.50%)
After hours: 05:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.87B
Enterprise value 6.15B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.81
Price/book (mrq)N/A
Enterprise value/revenue 28.07
Enterprise value/EBITDA -9.40

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 3-0.04%
S&P500 52-week change 332.96%
52-week high 344.32
52-week low 321.62
50-day moving average 325.91
200-day moving average 329.14

Share statistics

Avg vol (3-month) 31.92M
Avg vol (10-day) 31.83M
Shares outstanding 5188.03M
Implied shares outstanding 6188.03M
Float 8127.53M
% held by insiders 15.43%
% held by institutions 193.10%
Shares short (30 Sept 2024) 418.63M
Short ratio (30 Sept 2024) 46.34
Short % of float (30 Sept 2024) 415.25%
Short % of shares outstanding (30 Sept 2024) 49.91%
Shares short (prior month 30 Aug 2024) 417.71M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -207.11%
Operating margin (ttm)-7,963.47%

Management effectiveness

Return on assets (ttm)-48.44%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)219.12M
Revenue per share (ttm)1.25
Quarterly revenue growth (yoy)32.10%
Gross profit (ttm)N/A
EBITDA -496.59M
Net income avi to common (ttm)-453.82M
Diluted EPS (ttm)-2.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)447.77M
Total cash per share (mrq)2.38
Total debt (mrq)1.73B
Total debt/equity (mrq)N/A
Current ratio (mrq)4.59
Book value per share (mrq)-5.81

Cash flow statement

Operating cash flow (ttm)-414.88M
Levered free cash flow (ttm)-348.46M